Chemoembolization-induced arterial damage: Evaluation of three different chemotherapeutic protocols using epirubicin and miriplatin

Short-term therapeutic effects of transcatheter arterial chemoembolization using miriplatin–lipiodol suspension for hepatocellular carcinoma

(2012) Sota Oguro et al.   JAPANESE JOURNAL OF RADIOLOGY

Comparison of local control effects of superselective transcatheter arterial chemoembolization using epirubicin plus mitomycin C and miriplatin for hepatocellular carcinoma

(2012) Shiro Miyayama et al.   JAPANESE JOURNAL OF RADIOLOGY

Local tumor progression following lipiodol-based targeted chemoembolization of hepatocellular carcinoma: a retrospective comparison of miriplatin and epirubicin

(2012) Jin Iwazawa et al.   Cancer Management and Research

A randomized phase II trial of intra-arterial chemotherapy using SM-11355 (Miriplatin) for hepatocellular carcinoma

(2011) Takuji Okusaka et al.   INVESTIGATIONAL NEW DRUGS

Vascular Complications of Hepatic Artery After Transcatheter Arterial Chemoembolization in Patients With Hepatocellular Carcinoma

(2010) Eijun Sueyoshi et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Arterial Patency after Repeated Hepatic Artery Bland Particle Embolization

(2010) Joseph P. Erinjeri et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Angiographic evaluation of hepatic arterial damage after transarterial chemoembolization for hepatocellular carcinoma

(2008) Noboru Maeda et al.